Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
Nature Reviews. Immunology
|
October 22, 2020
Immunological considerations for SARS-CoV-2 human challenge studies
Alexander D Douglas, Adrian V S Hill
Frontiers in Immunology
|
June 15, 2026
Progress and prospects for herpesvirus vaccination using gB antigens
Solomon English, Adam Khan-Qureshi, Alexander D Douglas
Human Vaccines & Immunotherapeutics
|
June 20, 2013
Challenges of assessing the clinical efficacy of asexual blood-stage Plasmodium falciparum malaria vaccines
Susanne H Sheehy, Alexander D Douglas, Simon J Draper
Vaccine
|
January 12, 2025
Routine childhood rabies pre-exposure prophylaxis can be cost effective in low- and middle-income countries
Adam John Ritchie, Aronrag Meeyai, Caroline Trotter, et al.
Angiology
|
April 29, 2009
Evaluation of point-of-care activated partial thromboplastin time testing by comparison to laboratory-based assay for control of intravenous heparin
Alexander D Douglas, Jo Jefferis, Rishi Sharma, et al.
Nature Biotechnology
|
March 8, 2023
Rapid-response manufacturing of adenovirus-vectored vaccines
Carina C D Joe, Nitin Chopra, Piergiuseppe Nestola, et al.
NPJ Vaccines
|
June 5, 2023
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
Cheng Zhang, Adam Berg, Carina C D Joe, et al.
Scientific Reports
|
August 24, 2022
STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
Eriko Padron-Regalado, Marta Ulaszewska, Alexander D Douglas, et al.
The American Journal of Tropical Medicine and Hygiene
|
June 11, 2008
Blood-stage challenge for malaria vaccine efficacy trials: a pilot study with discussion of safety and potential value
Frances Sanderson, Laura Andrews, Alexander D Douglas, et al.
Vaccine
|
October 13, 2010
Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1
Alexander D Douglas, Simone C de Cassan, Matthew D J Dicks, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
Nature Reviews. Immunology
|
October 22, 2020
Immunological considerations for SARS-CoV-2 human challenge studies
Alexander D Douglas, Adrian V S Hill
Frontiers in Immunology
|
June 15, 2026
Progress and prospects for herpesvirus vaccination using gB antigens
Solomon English, Adam Khan-Qureshi, Alexander D Douglas
Human Vaccines & Immunotherapeutics
|
June 20, 2013
Challenges of assessing the clinical efficacy of asexual blood-stage Plasmodium falciparum malaria vaccines
Susanne H Sheehy, Alexander D Douglas, Simon J Draper
Vaccine
|
January 12, 2025
Routine childhood rabies pre-exposure prophylaxis can be cost effective in low- and middle-income countries
Adam John Ritchie, Aronrag Meeyai, Caroline Trotter, et al.
Angiology
|
April 29, 2009
Evaluation of point-of-care activated partial thromboplastin time testing by comparison to laboratory-based assay for control of intravenous heparin
Alexander D Douglas, Jo Jefferis, Rishi Sharma, et al.
Nature Biotechnology
|
March 8, 2023
Rapid-response manufacturing of adenovirus-vectored vaccines
Carina C D Joe, Nitin Chopra, Piergiuseppe Nestola, et al.
NPJ Vaccines
|
June 5, 2023
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
Cheng Zhang, Adam Berg, Carina C D Joe, et al.
Scientific Reports
|
August 24, 2022
STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
Eriko Padron-Regalado, Marta Ulaszewska, Alexander D Douglas, et al.
The American Journal of Tropical Medicine and Hygiene
|
June 11, 2008
Blood-stage challenge for malaria vaccine efficacy trials: a pilot study with discussion of safety and potential value
Frances Sanderson, Laura Andrews, Alexander D Douglas, et al.
Vaccine
|
October 13, 2010
Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1
Alexander D Douglas, Simone C de Cassan, Matthew D J Dicks, et al.
Page
of 7